Key result
Endothelial miR-217 expression promoted endothelial dysfunction, increased blood pressure, and exacerbated atherosclerosis in apoE-/- mice, while its inhibition improved vascular contractility.
Why the study?
Although miR-217 is associated with aging and cellular senescence, its role in vascular disease is not understood.
miR-217 promotes endothelial dysfunction and atherosclerosis by downregulating eNOS activators, suggesting miR-217 inhibitors have therapeutic potential in aging-related cardiovascular disease.
Answers are grounded in this paper and cite their sources.
miR-217 may represent a novel endothelial target; hypothesis-generating in mice, requires human validation before clinical consideration.
Objective: microRNAs are master regulators of gene expression with essential roles in virtually all biological processes. miR-217 has been associated with aging and cellular senescence, but its role in vascular disease is not understood. Approach and Results: We have used an inducible endothelium-specific knock-in mouse model to address the role of miR-217 in vascular function and atherosclerosis. miR-217 reduced NO production and promoted endothelial dysfunction, increased blood pressure, and exacerbated atherosclerosis in proatherogenic apoE −/ − mice. Moreover, increased endothelial miR-217 expression led to the development of coronary artery disease and altered left ventricular heart function, inducing diastolic and systolic dysfunction. Conversely, inhibition of endogenous vascular miR-217 in apoE −/− mice improved vascular contractility and diminished atherosclerosis. Transcriptome analysis revealed that miR-217 regulates an endothelial signaling hub and downregulates a network of eNOS (endothelial NO synthase) activators, including VEGF (vascular endothelial growth factor) and apelin receptor pathways, resulting in diminished eNOS expression. Further analysis revealed that human plasma miR-217 is a biomarker of vascular aging and cardiovascular risk. Conclusions: Our results highlight the therapeutic potential of miR-217 inhibitors in aging-related cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Yébenes et al. (2020) studied Atherosclerosis and cardiovascular dysfunction. miR-217 expression and inhibition was evaluated on Vascular function, atherosclerosis, and blood pressure. Endothelial miR-217 expression promoted endothelial dysfunction, increased blood pressure, and exacerbated atherosclerosis in apoE-/- mice, while its inhibition improved vascular contractility.
Synapse has enriched 10 related papers. Consider them for comparative context: